Myeloma Bone Disease: The Osteoblast in the Spotlight

Lytic bone disease remains a life-altering complication of multiple myeloma, with up to 90% of sufferers experiencing skeletal events at some point in their cancer journey. This tumour-induced bone disease is driven by an upregulation of bone resorption (via increased osteoclast (OC) activity) and a...

Descripción completa

Detalles Bibliográficos
Autores principales: Andrews, Rebecca E., Brown, Janet E., Lawson, Michelle A., Chantry, Andrew D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432062/
https://www.ncbi.nlm.nih.gov/pubmed/34501423
http://dx.doi.org/10.3390/jcm10173973

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432062/
https://www.ncbi.nlm.nih.gov/pubmed/34501423
http://dx.doi.org/10.3390/jcm10173973

Ejemplares similares